Cargando…

Targeting transcriptional regulators for treatment of anaplastic thyroid cancer

Dysregulation of genes perpetuates cancer progression. During carcinogenesis, cancer cells acquire dependency of aberrant transcriptional programs (known as “transcription addiction”) to meet the high demands for uncontrolled proliferation. The needs for particular transcription programs for cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Woo Kyung, Cheng, Sheue-Yann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577520/ https://www.ncbi.nlm.nih.gov/pubmed/34761120 http://dx.doi.org/10.20517/2394-4722.2021.58

Ejemplares similares

Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
por: Zhu, Xuguang, et al.
Publicado: (2018)

Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression
por: Fozzatti, Laura, et al.
Publicado: (2019)

Author Correction: Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression
por: Fozzatti, Laura, et al.
Publicado: (2019)

Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer
por: Zhu, Xuguang, et al.
Publicado: (2017)

Treatment outcomes of radiotherapy for anaplastic thyroid cancer
por: Park, Jong Won, et al.
Publicado: (2018)

Treatment Outcomes in Anaplastic Thyroid Cancer
por: Corrigan, Kelsey L., et al.
Publicado: (2019)

Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer
por: Fozzatti, Laura, et al.
Publicado: (2020)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
por: Lee, Jieun, et al.
Publicado: (2013)

Targeting the SUMO pathway as a novel treatment for anaplastic thyroid cancer
por: De Andrade, James P., et al.
Publicado: (2017)

Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation()()
por: Zhu, Xuguang, et al.
Publicado: (2014)

SUN-338 Inflammation Promotes Aggressive Thyroid Cancer Progression in a Mouse Model
por: Park, Sunmi, et al.
Publicado: (2019)

Anaplastic thyroid cancer: multimodal treatment results
por: Aslan, Zaki Antonio Taissoun, et al.
Publicado: (2014)

Salutary Response to Targeted Therapy in Anaplastic Thyroid Cancer
por: Fazeli, Sasan, et al.
Publicado: (2019)

Editorial: Translational research in thyroid cancer, Volume II
por: Cheng, Sheue-yann, et al.
Publicado: (2023)

Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Editorial: Translational Research in Thyroid Cancer
por: Vasko, Vasyl, et al.
Publicado: (2020)

Gene master regulators of papillary and anaplastic thyroid cancers
por: Iacobas, Dumitru A., et al.
Publicado: (2017)

FOXD3 regulates anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling
por: Ravi, Naveen, et al.
Publicado: (2019)

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2021)

Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha
por: Freudenthal, Bernard, et al.
Publicado: (2019)

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
por: Lee, Jin-Seok, et al.
Publicado: (2022)

Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism
por: Stempin, Cinthia Carolina, et al.
Publicado: (2021)

Risk Factors for Anaplastic Thyroid Cancer
por: Zivaljevic, V., et al.
Publicado: (2014)

Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?
por: Gao, Xiaoni, et al.
Publicado: (2023)

Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer
por: Akaishi, Junko, et al.
Publicado: (2006)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer
por: Kasemsiri, Pornthep, et al.
Publicado: (2021)

Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
por: Nagaiah, Govardhanan, et al.
Publicado: (2011)

Anaplastic Cancer of the Thyroid: The Viper in the Pit
por: Seshadri, Krishna G.
Publicado: (2019)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

The role of chemotherapy and latest emerging target therapies in anaplastic thyroid cancer
por: Denaro, Nerina, et al.
Publicado: (2013)

Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
por: Yuan, Jiaqian, et al.
Publicado: (2022)

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020)

Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer
por: Wächter, Sabine, et al.
Publicado: (2018)

Clinical Outcome and Toxicity in the Treatment of Anaplastic Thyroid Cancer in Elderly Patients
por: Augustin, Teresa, et al.
Publicado: (2020)

Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2023)

Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review
por: Guerra, Anna, et al.
Publicado: (2013)

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vkok9un1jdemvrl6i1qtb64sha